Back to search
Hemodialysis Subjects With Secondary Hyperparathyroidism
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hemodialysis Subjects With Secondary Hyperparathyroidism trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hemodialysis Subjects With Secondary Hyperparathyroidism trials you may qualify forThis is a phase 3 trial of etelcalcetide in pediatric participants with secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) on hemodialysis.
MT1013 is a first-in-class dual-target agonist.This study is being conducted to determine the mass balance and routes of excretion of total radioactivity after…
This is a multi-center, open, single-arm phase IIb clinical study comprising 2 parts, which Part A will enroll about 110 subjects, and Part B will enroll about…
Safety, Efficacy, PK and PD of CTAP101 (calcifediol) ER Capsules for SHPT in HD Patients VDI
The study is being conducted to determine the mass balance and routes of excretion of total radioactivity after the dose of \[14C\] SHR6508.
A multicenter, Phase II, randomized, double-blind, single ascending dose (SAD) and multiple ascending dose (MAD), as well as single-arm clinical study evaluatin…